[1]
“Chemotherapy-induced febrile neutropenia: risk factors, prophylaxis, and management with filgrastim in oncological patients”, Acervo Saúde, vol. 23, no. 10, p. e14375, Oct. 2023, doi: 10.25248/reas.e14375.2023.